ASX - By Stock
|
OCC |
Re:
Media thread
|
|
KainCarver
|
629 |
214K |
1 |
10/08/24 |
10/08/24 |
ASX - By Stock
|
629
|
214K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
KainCarver
|
629 |
214K |
2 |
10/08/24 |
10/08/24 |
ASX - By Stock
|
629
|
214K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q4 FY2024
|
|
KainCarver
|
59 |
19K |
16 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
59
|
19K
|
16
|
|
ASX - By Stock
|
OCC |
Re:
Stem Cell Therapy advancements
|
|
KainCarver
|
475 |
166K |
7 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
475
|
166K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
KainCarver
|
629 |
214K |
13 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
629
|
214K
|
13
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q4 FY2024
|
|
KainCarver
|
59 |
19K |
14 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
59
|
19K
|
14
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q4 FY2024
|
|
KainCarver
|
59 |
19K |
20 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
59
|
19K
|
20
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q4 FY2024
|
|
KainCarver
|
59 |
19K |
16 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
59
|
19K
|
16
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
KainCarver
|
1.7K |
552K |
18 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
1.7K
|
552K
|
18
|
|
ASX - By Stock
|
NC6 |
Re:
Ann: $200,000 R&D Loan Facility Secured
|
|
KainCarver
|
7 |
1.6K |
1 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
7
|
1.6K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
KainCarver
|
2.8K |
1.2M |
2 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
2.8K
|
1.2M
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
KainCarver
|
2.8K |
1.2M |
13 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
2.8K
|
1.2M
|
13
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
KainCarver
|
2.8K |
1.2M |
28 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
2.8K
|
1.2M
|
28
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
KainCarver
|
629 |
214K |
20 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
629
|
214K
|
20
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Global Market Expansion Accelerates - New Regions Pending
|
|
KainCarver
|
18 |
5.1K |
8 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
18
|
5.1K
|
8
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore strikes Exclusive Distribution with Zimmer Biomet
|
|
KainCarver
|
66 |
21K |
3 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
66
|
21K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
KainCarver
|
27 |
9.2K |
2 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
27
|
9.2K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Global Market Expansion Accelerates - New Regions Pending
|
|
KainCarver
|
18 |
5.1K |
17 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
18
|
5.1K
|
17
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Application for quotation of securities - 4DX
|
|
KainCarver
|
91 |
22K |
8 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
91
|
22K
|
8
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore strikes Exclusive Distribution with Zimmer Biomet
|
|
KainCarver
|
66 |
21K |
1 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
66
|
21K
|
1
|
|
ASX - By Stock
|
CXL |
Re:
Ann: Calix announces $15m grant for zero emissions plant
|
|
KainCarver
|
21 |
9.9K |
2 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
21
|
9.9K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Global Market Expansion Accelerates - New Regions Pending
|
|
KainCarver
|
18 |
5.1K |
15 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
18
|
5.1K
|
15
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Application for quotation of securities - 4DX
|
|
KainCarver
|
91 |
22K |
15 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
91
|
22K
|
15
|
|
ASX - By Stock
|
4DX |
Re:
News: 4DX 4Dmedical Ltd Says Entered Contract With Integral Diagnostics
|
|
KainCarver
|
6 |
2.6K |
3 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
6
|
2.6K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Orthocell Presentation - July 2024
|
|
KainCarver
|
6 |
2.0K |
8 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
6
|
2.0K
|
8
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore strikes Exclusive Distribution with Zimmer Biomet
|
|
KainCarver
|
66 |
21K |
2 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
66
|
21K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Orthocell Presentation - July 2024
|
|
KainCarver
|
6 |
2.0K |
5 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
6
|
2.0K
|
5
|
|
ASX - By Stock
|
NC6 |
Re:
General Discussion
|
|
KainCarver
|
1.3K |
360K |
0 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
1.3K
|
360K
|
0
|
|
ASX - By Stock
|
NC6 |
Re:
General Discussion
|
|
KainCarver
|
1.3K |
360K |
0 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
1.3K
|
360K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Application for quotation of securities - 4DX
|
|
KainCarver
|
91 |
22K |
11 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
91
|
22K
|
11
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
KainCarver
|
629 |
214K |
17 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
629
|
214K
|
17
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
KainCarver
|
629 |
214K |
14 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
629
|
214K
|
14
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
KainCarver
|
629 |
214K |
15 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
629
|
214K
|
15
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
KainCarver
|
629 |
214K |
16 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
629
|
214K
|
16
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore strikes Exclusive Distribution with Zimmer Biomet
|
|
KainCarver
|
66 |
21K |
0 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
66
|
21K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
KainCarver
|
27 |
9.2K |
1 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
27
|
9.2K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
KainCarver
|
27 |
9.2K |
19 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
27
|
9.2K
|
19
|
|
ASX - By Stock
|
OCC |
Re:
Stem Cell Therapy advancements
|
|
KainCarver
|
475 |
166K |
7 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
475
|
166K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
KainCarver
|
629 |
214K |
11 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
629
|
214K
|
11
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
KainCarver
|
2.8K |
1.2M |
3 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
2.8K
|
1.2M
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
KainCarver
|
2.8K |
1.2M |
10 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
2.8K
|
1.2M
|
10
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Application for quotation of securities - 4DX
|
|
KainCarver
|
91 |
22K |
7 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
91
|
22K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
KainCarver
|
2.8K |
1.2M |
5 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
2.8K
|
1.2M
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Regulatory Approval to Commence Sales for Striate in Canada
|
|
KainCarver
|
23 |
7.5K |
28 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
23
|
7.5K
|
28
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Regulatory Approval to Commence Sales for Striate in Canada
|
|
KainCarver
|
23 |
7.5K |
11 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
23
|
7.5K
|
11
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
KainCarver
|
629 |
214K |
10 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
629
|
214K
|
10
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
KainCarver
|
34 |
9.1K |
8 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
34
|
9.1K
|
8
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
KainCarver
|
34 |
9.1K |
12 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
34
|
9.1K
|
12
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Pause in Trading
|
|
KainCarver
|
15 |
3.3K |
7 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
15
|
3.3K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
KainCarver
|
2.8K |
1.2M |
18 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
2.8K
|
1.2M
|
18
|
|